Zhao J - Search Results

1

Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin America.

Queiroz Muniz D, Ratto B, Yang H, Zhao J, Jenkins M, Signorovitch J, Dezzani L, Salman P, Lema Medina M, Lopera D, Lerzo G, Del Castillo C, Chacon M, Martin A, Campos-Gomez S. Queiroz Muniz D, et al. Among authors: zhao j. Adv Ther. 2019 Dec;36(12):3446-3457. doi: 10.1007/s12325-019-01109-y. Epub 2019 Oct 19. Adv Ther. 2019. PMID: 31630333

2

Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis.

Li J, Sasane M, Zhao J, Horton VG, Zhang P, Ricculli ML, Zhou ZY, Signorovitch J. Li J, et al. Among authors: zhao j. Adv Ther. 2018 Jul;35(7):1035-1048. doi: 10.1007/s12325-018-0734-9. Epub 2018 Jun 15. Adv Ther. 2018. PMID: 29949047

3

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome.

Chen KS, Xie J, Tang W, Zhao J, Jeppesen PB, Signorovitch JE. Chen KS, et al. Among authors: zhao j. Ther Clin Risk Manag. 2018 Jul 25;14:1267-1277. doi: 10.2147/TCRM.S166081. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30100725 Free PMC article.

4

Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data.

Li J, Sasane M, Zhang J, Zhao J, Ricculli ML, Yao Z, Redhu S, Signorovitch J. Li J, et al. Among authors: zhao j. BMJ Open. 2018 Aug 17;8(8):e021642. doi: 10.1136/bmjopen-2018-021642. BMJ Open. 2018. PMID: 30121602 Free PMC article. Clinical Trial.

5

Matching-adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Other Targeted Therapies in Relapsed/Refractory Mantle Cell Lymphoma.

Telford C, Kabadi SM, Abhyankar S, Song J, Signorovitch J, Zhao J, Yao Z. Telford C, et al. Among authors: zhao j. Clin Ther. 2019 Nov;41(11):2357-2379.e1. doi: 10.1016/j.clinthera.2019.09.012. Epub 2019 Nov 4. Clin Ther. 2019. PMID: 31699438 Free article.

6

Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes.

Marden JR, Santos C, Pfister B, Able R, Lane H, Somma M, Zhao J, Signorovitch J, Parsons J, Apkon S. Marden JR, et al. Among authors: zhao j. J Comp Eff Res. 2021 Oct;10(14):1065-1078. doi: 10.2217/cer-2021-0110. Epub 2021 Jul 19. J Comp Eff Res. 2021. PMID: 34275333 Free article.

7

Real-world treatment patterns and clinical outcomes for inpatients with COVID-19 in the US from September 2020 to February 2021.

Ayodele O, Ren K, Zhao J, Signorovitch J, Jonsson Funk M, Zhu J, Bao Y, Gondek K, Keenan H; R&D COVID Alliance. Ayodele O, et al. Among authors: zhao j. PLoS One. 2021 Dec 28;16(12):e0261707. doi: 10.1371/journal.pone.0261707. eCollection 2021. PLoS One. 2021. PMID: 34962924 Free PMC article.

8

Overall survival in the real-world and clinical trials: a case study validating external controls in advanced melanoma.

Signorovitch J, Moshyk A, Zhao J, Le TK, Burns L, Gooden K, Hamilton M. Signorovitch J, et al. Among authors: zhao j. Future Oncol. 2022 Apr;18(11):1321-1331. doi: 10.2217/fon-2021-1054. Epub 2022 Jan 20. Future Oncol. 2022. PMID: 35048743 Free article.

9

Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States.

Maziarz RT, Yang H, Liu Q, Wang T, Zhao J, Lim S, Lee S, Dalal A, Bollu V. Maziarz RT, et al. Among authors: zhao j. Leuk Lymphoma. 2022 Sep;63(9):2052-2062. doi: 10.1080/10428194.2022.2060503. Epub 2022 Apr 14. Leuk Lymphoma. 2022. PMID: 35422192

10

Healthcare resource use and reimbursement amount by site of care in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell (CAR-T) therapy - a retrospective cohort study using CMS 100% Medicare claims database.

Yang H, Bollu V, Lim S, Tesfaye M, Dalal AA, Lax A, Sethi S, Zhao J. Yang H, et al. Among authors: zhao j. Leuk Lymphoma. 2023 Feb;64(2):339-348. doi: 10.1080/10428194.2022.2147395. Epub 2022 Nov 21. Leuk Lymphoma. 2023. PMID: 36408973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53,205 results

Search Page